Michael Korenkov
@kormichi.bsky.social
Resident in Haematology/Oncology @Charite! Former member of @KleinLab at Uniklinik Köln. Interested in leukemia and myeloma care. Currently learning to apply single cell technologies in myeloma @MDC
We report two cases of severe CIDP following cilta-cel therapy. Findings suggest bystander activation of CD8⁺ non-CAR-T cells rather than direct CAR-T toxicity. Timely T-cell–depleting therapy with cyclophosphamide may improve outcomes. Out now in the Blood Cancer Journal!
October 21, 2025 at 8:42 AM
We report two cases of severe CIDP following cilta-cel therapy. Findings suggest bystander activation of CD8⁺ non-CAR-T cells rather than direct CAR-T toxicity. Timely T-cell–depleting therapy with cyclophosphamide may improve outcomes. Out now in the Blood Cancer Journal!